Form 4: Vaxcyte CEO Grant Pickering Reports Stock Transaction
SEC Form 4 Filing
Vaxcyte's CEO, Grant Pickering, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On September 3, 2024, Grant Pickering, the CEO of Vaxcyte, Inc., disposed of 13,669 shares of common stock to cover tax withholding obligations.
- The shares were disposed of at a price of $110.15 per share.
- Following the transaction, Pickering directly owns 465,219 shares of Vaxcyte common stock.
- Pickering also indirectly owns 142,130 shares through a trust for his daughter and 142,130 shares through a trust for his son.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate a change in the executive's overall confidence in the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/03/2024 | Date of stock transaction (disposal of shares). |
| 09/04/2024 | Date of Lock-Up Agreement. |
| 09/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.